Estimated number of new cancer cases attributable to infection in the Netherlands in 2003

Cancer Letters

Volumn 272, Issue 2, 2008, Pages 226-231

  van Lier, Elizabeth A ^a   van Kranen, Henk J ^a   van Vliet, Johannes A ^a   Rahamat Langendoen, Janna C ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Attributable fraction; Cancer; Estimates; Infection; The Netherlands

Indexed keywords

ARTICLE; BURKITT LYMPHOMA; CANCER RISK; CAUSAL ATTRIBUTION; EPSTEIN BARR VIRUS; HELICOBACTER PYLORI; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTION; KAPOSI SARCOMA; LIVER CANCER; MAJOR CLINICAL STUDY; NASOPHARYNX CANCER; NEOPLASM; NETHERLANDS; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STOMACH CANCER; T CELL LEUKEMIA; T CELL LYMPHOMA; UTERINE CERVIX CANCER; WART VIRUS;

HUMANS; INFECTION; NEOPLASMS; NETHERLANDS;

HELICOBACTER PYLORI; HUMAN PAPILLOMAVIRUS;

EID: 55949083948     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.07.007     Document Type: Article

References (31)

1. Herrera L.A., Benitez-Bribiesca L., Mohar A., and Ostrosky-Wegman P. Role of infectious diseases in human carcinogenesis. Environ. Mol. Mutagen. 45 2-3 (2005) 284-303
2. Mueller N. Overview: viral agents and cancer. Environ. Health Perspect. 103 Suppl 8 (1995) 259-261
3. Persing D.H., and Prendergast F.G. Infection, immunity, and cancer. Arch. Pathol. Lab. Med. 123 11 (1999) 1015-1022
4. Kuper H., Adami H.O., and Trichopoulos D. Infections as a major preventable cause of human cancer. J. Intern. Med. 248 3 (2000) 171-183
5. Cassell G.H. Infectious causes of chronic inflammatory diseases and cancer. Emerg. Infect. Dis. 4 3 (1998) 475-487
6. Vogelmann R., and Amieva M.R. The role of bacterial pathogens in cancer. Curr. Opin. Microbiol. 10 1 (2007) 76-81
7. Balkwill F., Charles K.A., and Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7 3 (2005) 211-217
8. Malignant neoplasms associated with infectious agents, in: D.L. Heymann (Ed.), Control of Communicable Disease Manual, American Public Health Association, Washington, 2004, pp. 340-347.
9. Davis D.L., and Muir C. Estimating avoidable causes of cancer. Environ. Health Perspect. 103 Suppl. 8 (1995) 301-306
10. Smolinski S., Hamburg M.A., and Lederberg J. Microbial Threats to Health: Emergence, Detection, and Response (2003), Institute of Medicine of the National Academies, Washington D.C.
11. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118 12 (2006) 3030-3044
12. WHO. The World Health Report 1996: Fighting Disease, Fostering Development (1996), World Health Organization, Geneva
13. Association of Comprehensive Cancer Centres, Netherlands Cancer Registry (NCR): national incidence data 2003, ACCC, Utrecht, 2007.
14. IARC, Monographs on the evaluation of carcinogenic risks to humans, Volume 59 Hepatitis Viruses, IARC, Lyon, 1994.
15. IARC, Monographs on the evaluation of carcinogenic risks to humans, Volume 90 Human papillomaviruses, IARC, Lyon, 2007.
16. IARC, Monographs on the evaluation of carcinogenic risks to humans, Volume 61 Schistosomes, Liver Flukes and Helicobacter pylori, IARC, Lyon, 1994.
17. IARC, Monographs on the evaluation of carcinogenic risks to humans, Volume 70 Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8, IARC, Lyon, 1997.
18. IARC, Monographs on the evaluation of carcinogenic risks to humans, Volume 67 Human Immunodeficiency Viruses and Human T-Cell Lymphotrophic Viruses, IARC, Lyon, 1996.
19. Nyren O., and Blot W.J. Helicobacter pylori infection: mainly foe but also friend?. J. Natl. Cancer Inst. 98 20 (2006) 1432-1434
20. Parkin D.M., and Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 24 Suppl. 3 (2006) S11-S25
21. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2 5 (2002) 342-350
22. Shah K.V. Do human papillomavirus infections cause oral cancer?. J. Natl. Cancer Inst. 90 21 (1998) 1585-1586
23. Bruix J., Boix L., Sala M., and Llovet J.M. Focus on hepatocellular carcinoma. Cancer Cell 5 3 (2004) 215-219
24. Van Steenbergen J.E., and Timen A. Protocols Infectious Diseases Edition 2006 (2006), National Coördination Structure Infectious Disease Control, Bilthoven
25. Roosendaal R., Kuipers E.J., Buitenwerf J., van Uffelen C., Meuwissen S.G., van Kamp G.J., et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am. J. Gastroenterol. 92 9 (1997) 1480-1482
26. Loffeld R.J. Infection with Helicobacter pylori, the end in sight?. Ned. Tijdschr. Geneeskd. 140 49 (1996) 2440-2441
27. Health Council. Stomach Complaints Publication No. 2000/26 (2000), Health Council, The Hague, the Netherlands
28. Veldhuijzen I.K., Conyn-van Spaendonck M.A.E., and Dorigo-Zetsmab J.W. Seroprevalence of hepatitis B and C in the Netherlands. Infectiez. Bull. 10 9 (1999) 182-184
29. van der Ploeg C.P., Kateman H., Vermeer-de Bondt P.E., and Verkerk P.H. Increased risk of hepatitis B due to incomplete or untimely immunisation in one-quarter of infants of hepatitis-B- virus carriers. Ned. Tijdschr. Geneeskd. 148 37 (2004) 1820-1824
30. Health Council: Commission Hepatitis C. Tracing and treatment of people with hepatitis C, Publication No. 1997/19. Rijswijk, the Netherlands: Health Council; 1997.
31. M.J.W. Van de Laar, E.L.M. Op de Coul. HIV and Sexually Transmitted Infections in the Netherlands in 2003 (RIVM report 441100020), National Institute for Public Health and the Environment (RIVM), Bilthoven, 2004.